Open Site Navigation
About Our Business

NovaXS is a therapeutic startup focused on improving treatment efficacy through an advanced drug delivery platform and innovative CRISPR gene therapy nanoparticle delivery. 

Our Vision

To build a needle-free, transformative, and interactive drug delivery platform and present to the market a world-leading and life-changing biological proteins that treat chronic diseases.

Meet the Team

NovaXS is founded out of UC Berkeley

QB3 Laboratory led by world-famous regenerative medicine expert Professor Irina Conboy and a professional team in healthcare with a proven track record of over 40 million fundraising experience and 5 successful business exits.

Founders

Alina
Su

CEO

Harvard Medical School

Ph.D. candidate  6 medical devices inventor Economist Intelligence Unit healthcare leader

  • LinkedIn
Jonathan
Xing

COO

UChicago Booth Part-time MBA Serial Entrepreneur 20x previous exit NBA Celebrity Resources

  • LinkedIn
Irina
Conboy Ph.D.

CSO

UCB bioengineering professor Regenerative medicine and CRISPR expert

  • LinkedIn
Alex
Zou

CTO 

EE Ph.D. candidate UC Berkeley EE Ph.D. candidate Industrial engineer

  • LinkedIn
Reed
McCalmon

CFO

10 years in biotech finance

  • LinkedIn
Sean
McKibben

Doctor Relations

Former hospital President

  • LinkedIn
Mike
Conboy

Scientific Advisor

UC Berkeley bioengineering instructor

  • LinkedIn
Mike
Grandinetti

Scientific advisor

Harvard Director

  • LinkedIn
Yong
Wu MD, Ph.D.

Scientific advisor

UCLA Medicine School
20 years in orphan drugs

  • LinkedIn
James G.
Wetrich

Board advisor

30 years CEO in MedTech

  • LinkedIn
Chris
Holliday

Board advisor

Senior advisor for Obama
Google Venture Board

  • LinkedIn
David
Harrell

Board advisor

IPO founder & CEO
of OptimizeRX

  • LinkedIn

Team

Participants in

Invested by

Featured on